The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadley, G. A.
Right arrow Articles by Moainie, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadley, G. A.
Right arrow Articles by Moainie, S.

The Journal of Immunology, Vol 159, Issue 8 3748-3756, Copyright © 1997 by American Association of Immunologists


ARTICLES

The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL

GA Hadley, ST Bartlett, CS Via, EA Rostapshova and S Moainie
Department of Surgery, University of Maryland Medical School, Baltimore 21201, USA. GHADLEY@SURGERY2.AB.UMD.EDU

The interaction of CD8+CTL with epithelial layers is an important but poorly defined aspect of organ allograft rejection. We herein report that CD103 (formerly alpha E integrin), a known receptor for the epithelial cell-specific ligand E-cadherin, is expressed by a major subset of CD8 + CTL elicited in response to allogeneic renal epithelial cells (REC). In contrast, CD103 was expressed poorly on CD8 + CTL generated in the conventional manner by stimulation with allogeneic leukocytes, although expression could be dramatically up-regulated by supplementing cultures with REC or exogenous TGF-beta 1. That TGF-beta controls the expression of CD103 on CD8+ CTL was further supported by the capacity of anti-TGF-beta mAb to block the generation of such cells in anti-REC cultures. Clonal analyses of anti-REC cultures revealed that individual CD8+ CTL clones were discretely CD103+ or CD103-, nd maintained their respective phenotypes independently of the cell type used for clonal restimulation. In a mouse model of graft-vs-host disease, 16.4 +/- 2.7% of CD8 cells that infiltrated host kidneys were CD103+ (n = 4). CD8 kidney-infiltrating lymphocytes were predominantly of donor origin and displayed an activated/memory phenotype (CD62L-, CD44high), consistent with expression of CD103 on a CD8 effector subset elicited in vivo following allogeneic transplantation. Taken together, the present data demonstrate that CD103 identifies a novel CD8 effector subset and, moreover, that such cells may comprise a significant component of the response to allogeneic tissues. The potential for CD103+ CTL as an important effector mechanism in organ allograft rejection, and more generally, as a mechanistic basis for tissue- specific immune phenomena, is discussed.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Terabe, Y. Tagaya, Q. Zhu, L. Granger, M. Roederer, T. A. Waldmann, and J. A. Berzofsky
IL-15 Expands Unconventional CD8{alpha}{alpha}NK1.1+ T Cells but Not V{alpha}14J{alpha}18+ NKT Cells
J. Immunol., June 1, 2008; 180(11): 7276 - 7286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ho, C. C. Kurtz, M. Naganuma, P. B. Ernst, F. Cominelli, and J. Rivera-Nieves
A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis
J. Immunol., February 15, 2008; 180(4): 2573 - 2580.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Mucida, Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre
Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Science, July 13, 2007; 317(5835): 256 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. L. Floc'h, A. Jalil, I. Vergnon, B. L. M. Chansac, V. Lazar, G. Bismuth, S. Chouaib, and F. Mami-Chouaib
{alpha}E{beta}7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis
J. Exp. Med., March 19, 2007; 204(3): 559 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Uss, A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. W. van Lier, and I. J. M. ten Berge
CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells.
J. Immunol., September 1, 2006; 177(5): 2775 - 2783.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Chancey, K. V. Khanna, J. F. M. L. Seegers, G. W. Zhang, J. Hildreth, A. Langan, and R. B. Markham
Lactobacilli-Expressed Single-Chain Variable Fragment (scFv) Specific for Intercellular Adhesion Molecule 1 (ICAM-1) Blocks Cell-Associated HIV-1 Transmission across a Cervical Epithelial Monolayer
J. Immunol., May 1, 2006; 176(9): 5627 - 5636.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein
CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Lunsford, M. A. Koester, A. M. Eiring, P. H. Horne, D. Gao, and G. L. Bumgardner
Targeting LFA-1 and CD154 Suppresses the In Vivo Activation and Development of Cytolytic (CD4-Independent) CD8+ T Cells
J. Immunol., December 15, 2005; 175(12): 7855 - 7866.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yuan, R. El-Asady, K. Liu, D. Wang, C. B. Drachenberg, and G. A. Hadley
Critical Role for CD103+CD8+ Effectors in Promoting Tubular Injury following Allogeneic Renal Transplantation
J. Immunol., September 1, 2005; 175(5): 2868 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Grueter, M. Petter, T. Egawa, K. Laule-Kilian, C. J. Aldrian, A. Wuerch, Y. Ludwig, H. Fukuyama, H. Wardemann, R. Waldschuetz, et al.
Runx3 Regulates Integrin {alpha}E/CD103 and CD4 Expression during Development of CD4-/CD8+ T Cells
J. Immunol., August 1, 2005; 175(3): 1694 - 1705.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Wang, R. Yuan, Y. Feng, R. El-Asady, D. L. Farber, R. E. Gress, P. J. Lucas, and G. A. Hadley
Regulation of CD103 Expression by CD8+ T Cells Responding to Renal Allografts
J. Immunol., January 1, 2004; 172(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Feng, D. Wang, R. Yuan, C. M. Parker, D. L. Farber, and G. A. Hadley
CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8+ T Cells
J. Exp. Med., October 7, 2002; 196(7): 877 - 886.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Lehmann, J. Huehn, M. de la Rosa, F. Maszyna, U. Kretschmer, V. Krenn, M. Brunner, A. Scheffold, and A. Hamann
Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells
PNAS, October 1, 2002; 99(20): 13031 - 13036.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Stevceva, B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini
Cervicovaginal Lamina Propria Lymphocytes: Phenotypic Characterization and Their Importance in Cytotoxic T-Lymphocyte Responses to Simian Immunodeficiency Virus SIVmac251
J. Virol., January 1, 2002; 76(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. C. Biedermann and J. S. Pober
Human Vascular Endothelial Cells Favor Clonal Expansion of Unusual Alloreactive CTL
J. Immunol., June 15, 1999; 162(12): 7022 - 7030.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. G. Higgins, M. Cernadas, K. Tan, A. Irie, J.-h. Wang, Y. Takada, and M. B. Brenner
The Role of alpha and beta Chains in Ligand Recognition by beta 7 Integrins
J. Biol. Chem., August 11, 2000; 275(33): 25652 - 25664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.